1. Home
  2. LFMD vs CRBU Comparison

LFMD vs CRBU Comparison

Compare LFMD & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LifeMD Inc.

LFMD

LifeMD Inc.

HOLD

Current Price

$4.76

Market Cap

236.7M

Sector

Health Care

ML Signal

HOLD

Logo Caribou Biosciences Inc.

CRBU

Caribou Biosciences Inc.

HOLD

Current Price

$1.95

Market Cap

192.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LFMD
CRBU
Founded
1994
2011
Country
United States
United States
Employees
384
97
Industry
Medical/Nursing Services
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
236.7M
192.4M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
LFMD
CRBU
Price
$4.76
$1.95
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
4
Target Price
$9.14
$10.75
AVG Volume (30 Days)
1.3M
1.4M
Earning Date
05-06-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
3.64
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$17.52
$1.63
Revenue Next Year
$18.73
$10.93
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.60
$0.77
52 Week High
$15.34
$3.53

Technical Indicators

Market Signals
Indicator
LFMD
CRBU
Relative Strength Index (RSI) 56.22 47.04
Support Level $3.39 $1.70
Resistance Level $4.93 $2.04
Average True Range (ATR) 0.36 0.12
MACD -0.00 -0.03
Stochastic Oscillator 47.16 20.54

Price Performance

Historical Comparison
LFMD
CRBU

About LFMD LifeMD Inc.

LifeMD Inc is a patient-centric, direct-to-patient healthcare company providing a high-quality, cost-effective, and convenient way for patients to access virtual medical care and pharmacy services. The Company's portfolio of brands within continuing operations is now managed as a single operating segment, Telehealth. Telehealth platform integrates core capabilities, includes: A nationwide pharmacy network, A wholly-owned commercial pharmacy, A fully integrated patient care center, A direct-to-patient marketing infrastructure for acquisition and retention, and AI-enabled clinical and operational technologies.

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The company is focused on advancing two clinical-stage allogeneic CAR-T cell therapy product candidates for the treatment of patients with hematologic malignancies: Vispacabtagene regedleucel and CB-011. It operates in one reportable segment, which is the business of developing allogeneic CAR-T cell therapies. Geographically, it operates in the United States and the rest of the World, of which the United States derives the maximum revenue.

Share on Social Networks: